To further determine hsa_circ_0001869/miR-638 axis regulatory mechanism for NSCLC progression, we conducted bioinformatics analysis and found that FOS-like antigen 2 (FOSL2) was the miR-638 downstream target. Here, FOSL2 is linked to non-small cell lung carcinoma.